Dow Down0.20% Nasdaq Down0.09%

Abbott Laboratories (ABT)

-NYSE

34.97 Down 0.06(0.17%) Aug 16, 4:02PM EDT|After Hours : 34.88 Down 0.09 (0.26%) Aug 16, 4:42PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Total Revenue 39,873,910   38,851,259   35,166,721  
Cost of Revenue15,119,718  15,540,580  14,665,192  
Gross Profit 24,754,192   23,310,679   20,501,529  
Operating Expenses
Research Development4,322,182  4,129,414  3,724,424  
Selling General and Administrative12,059,495  12,756,817  10,376,324  
Non Recurring288,000  672,500  313,200  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 8,084,515   5,751,948   6,087,581  
Income from Continuing Operations
Total Other Income/Expenses Net(1,229,498)(23,165)178,388  
Earnings Before Interest And Taxes6,855,017  5,728,783  6,265,969  
Interest Expense592,403  530,141  553,135  
Income Before Tax6,262,614  5,198,642  5,712,834  
Income Tax Expense299,694  470,193  1,086,662  
Minority Interest -   -   -  
Net Income From Continuing Ops4,611,947  4,728,449  4,626,172  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 5,962,920   4,728,449   4,626,172  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 5,962,920   4,728,449   4,626,172  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.